This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Crespo, M. P.
Right arrow Articles by Livermore, D. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Crespo, M. P.
Right arrow Articles by Livermore, D. M.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2004, p. 5094-5101, Vol. 42, No. 11
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.11.5094-5101.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.

Outbreak of Carbapenem-Resistant Pseudomonas aeruginosa Producing VIM-8, a Novel Metallo-ß-Lactamase, in a Tertiary Care Center in Cali, Colombia

M. P. Crespo,1* N. Woodford,2 A. Sinclair,2 M. E. Kaufmann,2 J Turton,2 J. Glover,2 J. D. Velez,3 C. R. Castañeda,3 M. Recalde,3 and D. M. Livermore2

Group of Medical Microbiology and Infectious Diseases, Universidad Santiago de Cali,1 Infectology Division and Clinical Laboratory, Fundación Clinica Valle del Lili, Cali, Colombia,3 Specialist and Reference Microbiology Division, Health Protection Agency—Colindale, London, United Kingdom2

Received 4 April 2004/ Returned for modification 27 April 2004/ Accepted 5 July 2004

The prevalence of imipenem resistance among Pseudomonas aeruginosa isolates at a 195-bed tertiary care medical center in Cali, Colombia, rose from 2% in 1996 to 28% in 1997 and to over 40% in 2003. Many isolates showed high-level multiresistance, and phenotypic characterization suggested the spread of a predominant strain with minor variants. Sixty-six resistant isolates collected between February 1999 and July 2003 from hospitalized patients (n = 54) and environmental samples (n = 12) were subjected to a fuller analysis. Genetic fingerprints were compared by pulsed-field gel electrophoresis (PFGE) of SpeI-digested genomic DNA, and blaIMP and blaVIM genes were sought by PCR. PFGE and serotyping indicated that 52 of the 66 isolates belonged to a single strain, with 82% similarity; the PFGE pattern for this organism was designated pattern A. Two further pairs of isolates represented single strains; the remaining nine isolates were unique, and in the case of one isolate, no satisfactory PFGE profile could be obtained. The pattern A isolates were mostly of serotype O12 and were highly resistant to imipenem (MICs, 32 to >256 µg/ml), with this resistance decreased eightfold or more in the presence of EDTA. They yielded amplicons with blaVIM-specific primers, and sequencing of DNA from a representative isolate revealed blaVIM-8, a novel allele with three polymorphisms compared with the sequence of blaVIM-2. Two of these nucleotide changes were silent, but the third determined a Thr139Ala substitution. Only 4 of 13 resistant isolates (2 clinical isolates and 2 environmental isolates) assigned to other PFGE types carried blaVIM alleles, whereas the others were less multiresistant and mostly had lower levels of imipenem resistance (MICs, ≤32 µg/ml) which was not significantly reduced by EDTA. No blaIMP alleles were detected. During 2003, when the environmental study was undertaken, serotype O12 isolates with blaVIM were recovered from sinks and stethoscopes in the most-affected units, although not from the hands of staff; the problem declined once these reservoirs were disinfected and hygienic precautions were reinforced.

* Corresponding author. Mailing address: Group of Medical Microbiology and Infectious Diseases, Universidad Santiago de Cali, Carrera 74 A # 11 A 17, Cali, Colombia. Phone: 572-3398410. Fax: 572-2731927. E-mail: macrespo{at}emcali.net.co.

Journal of Clinical Microbiology, November 2004, p. 5094-5101, Vol. 42, No. 11
0095-1137/04/$08.00+0     DOI: 10.1128/JCM.42.11.5094-5101.2004
Copyright © 2004, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:

  • Strateva, T., Yordanov, D. (2009). Pseudomonas aeruginosa - a phenomenon of bacterial resistance. J Med Microbiol 58: 1133-1148 [Abstract] [Full Text]  
  • Chin, J. N., Jones, R. N., Sader, H. S., Savage, P. B., Rybak, M. J. (2008). Potential synergy activity of the novel ceragenin, CSA-13, against clinical isolates of Pseudomonas aeruginosa, including multidrug-resistant P. aeruginosa. J Antimicrob Chemother 61: 365-370 [Abstract] [Full Text]  
  • Queenan, A. M., Bush, K. (2007). Carbapenemases: the Versatile {beta}-Lactamases. Clin. Microbiol. Rev. 20: 440-458 [Abstract] [Full Text]  
  • Villegas, M. V., Lolans, K., Correa, A., Kattan, J. N., Lopez, J. A., Quinn, J. P., and the Colombian Nosocomial Resistance Study Grou, (2007). First Identification of Pseudomonas aeruginosa Isolates Producing a KPC-Type Carbapenem-Hydrolyzing {beta}-Lactamase. Antimicrob. Agents Chemother. 51: 1553-1555 [Abstract] [Full Text]  
  • Hawkyard, C. V., Koerner, R. J. (2007). The use of erythromycin as a gastrointestinal prokinetic agent in adult critical care: benefits versus risks. J Antimicrob Chemother 59: 347-358 [Abstract] [Full Text]  
  • Libisch, B., Muzslay, M., Gacs, M., Minarovits, J., Knausz, M., Watine, J., Ternak, G., Kenez, E., Kustos, I., Rokusz, L., Szeles, K., Balogh, B., Fuzi, M. (2006). Molecular Epidemiology of VIM-4 Metallo-{beta}-Lactamase-Producing Pseudomonas sp. Isolates in Hungary. Antimicrob. Agents Chemother. 50: 4220-4223 [Abstract] [Full Text]  
  • Giske, C. G., Libisch, B., Colinon, C., Scoulica, E., Pagani, L., Fuzi, M., Kronvall, G., Rossolini, G. M. (2006). Establishing Clonal Relationships between VIM-1-Like Metallo-{beta}-Lactamase-Producing Pseudomonas aeruginosa Strains from Four European Countries by Multilocus Sequence Typing. J. Clin. Microbiol. 44: 4309-4315 [Abstract] [Full Text]  
  • Zavascki, A. P., Barth, A. L., Goncalves, A. L. S., Moro, A. L. D., Fernandes, J. F., Martins, A. F., Ramos, F., Goldani, L. Z. (2006). The influence of metallo-{beta}-lactamase production on mortality in nosocomial Pseudomonas aeruginosa infections. J Antimicrob Chemother 58: 387-392 [Abstract] [Full Text]  
  • Struble, J. M., Gill, R. T. (2006). Reverse Engineering Antibiotic Sensitivity in a Multidrug-Resistant Pseudomonas aeruginosa Isolate.. Antimicrob. Agents Chemother. 50: 2506-2515 [Abstract] [Full Text]  
  • Villegas, M. V., Lolans, K., del Rosario Olivera, M., Suarez, C. J., Correa, A., Queenan, A. M., Quinn, J. P., the Colombian Nosocomial Resistance Study Group, (2006). First Detection of Metallo-{beta}-Lactamase VIM-2 in Pseudomonas aeruginosa Isolates from Colombia. Antimicrob. Agents Chemother. 50: 226-229 [Abstract] [Full Text]  
  • Marra, A. R., Pereira, C. A. P., Gales, A. C., Menezes, L. C., Cal, R. G. R., de Souza, J. M. A., Edmond, M. B., Faro, C., Wey, S. B. (2006). Bloodstream Infections with Metallo-{beta}-Lactamase-Producing Pseudomonas aeruginosa: Epidemiology, Microbiology, and Clinical Outcomes. Antimicrob. Agents Chemother. 50: 388-390 [Abstract] [Full Text]  
  • Lolans, K., Queenan, A. M., Bush, K., Sahud, A., Quinn, J. P. (2005). First Nosocomial Outbreak of Pseudomonas aeruginosa Producing an Integron-Borne Metallo-{beta}-Lactamase (VIM-2) in the United States. Antimicrob. Agents Chemother. 49: 3538-3540 [Abstract] [Full Text]  
  • Pitout, J. D. D., Gregson, D. B., Poirel, L., McClure, J.-A., Le, P., Church, D. L. (2005). Detection of Pseudomonas aeruginosa Producing Metallo-{beta}-Lactamases in a Large Centralized Laboratory. J. Clin. Microbiol. 43: 3129-3135 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»